Health-related quality of life and cost-effectiveness studies in the European randomised study of screening for prostate cancer and the US Prostate, Lung, Colon and Ovary trial - Miller, A.B; Madalinska, J.B; Church, T; Crawford, D; Essink-Bot, M.L; Goel, V; de Koning, H.J; Määttänen, L; Pentikäinen, T (European Journal of Cancer, 2001)
Keywords: Biological and medical sciences; Colonic Neoplasms - diagnosis; Colonic Neoplasms - economics; Cost effectiveness; Cost-Benefit Analysis; Female; Gynecology. Andrology. Obstetrics; Humans; Lung Neoplasms - diagnosis; Lung Neoplasms - economics; Male; Male genital diseases; Mass Screening - economics; Medical sciences; Ovarian Neoplasms - diagnosis; Ovarian Neoplasms - economics; Prostate cancer; Prostatic Neoplasms - diagnosis; Prostatic Neoplasms - economics; Quality of Life; Randomized Controlled Trials as Topic; Screening; Tumors; Europe; Screening; Cost effectiveness; Prostate cancer; Quality of life; Human; Urinary system disease; Prostate disease; Health economy; Male; Malignant tumor; Medical screening; Male genital diseases; Epidemiology; Prostate; Cost efficiency analysis